Why might a bone marrow transplant fail in high-risk myeloma, even when the disease seemed controlled beforehand? It's a really important question, and unfortunately a frustrating reality for some people.
Even when myeloma appears controlled before transplant, high-risk disease has biological features that make it harder to Show Full Answer
Why might a bone marrow transplant fail in high-risk myeloma, even when the disease seemed controlled beforehand? It's a really important question, and unfortunately a frustrating reality for some people.
Even when myeloma appears controlled before transplant, high-risk disease has biological features that make it harder to eliminate completely. Here are some key reasons:
- Minimal residual disease (MRD): Tiny amounts of myeloma cells can remain undetected even after good responses, and these can regrow after transplant
- High-risk genetic features: Certain chromosomal changes (like del(17p) or t(4;14)) make myeloma cells more aggressive and resistant to high-dose chemotherapy used during conditioning
- Immune system weakness: The transplant process itself suppresses immunity, giving any remaining myeloma cells an opportunity to recover
- Incomplete conditioning: High-dose chemo may not destroy every myeloma cell, especially in high-risk disease
- Relapse biology: High-risk myeloma tends to relapse faster and more aggressively, sometimes before the transplanted cells fully establish themselves
This is why maintenance therapy after transplant is considered so important — it helps keep any remaining cells in check for as long as possible.
Always worth discussing with your specialist whether additional strategies, like tandem transplants or intensified maintenance, might apply to your situation.
3 days ago
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
